Physician profile
Markus Velten
NPI 1578335568
$12,160.83
in general payments reported to CMS, 2019-2025
11 companies · $3,569 in 2025
The $3,569 reported for 2025 was more than what 98% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $8,591 · 2025: $3,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,343 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,255 · Honoraria: $2,000 · Food and Beverage: $1,373 · Consulting Fee: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,342.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,255.38 |
| Honoraria | $2,000.00 |
| Food and Beverage | $1,372.79 |
| Consulting Fee | $190.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $8,208.66 | 2024 | |
| Octapharma USA, INC. | $2,577.94 | 2025 | Fibryga & Balfaxar, Fibryga, Panzyga |
| Ge Healthcare | $227.85 | 2025 | |
| Artivion, INC. | $203.13 | 2025 | Cryovalve Sg Pulmonary Human Heart Valve, Amds-Ascyrus Medical |
| La Jolla Pharmaceutical Company | $195.17 | 2024-2025 | Giapreza |
| Bolton Medical INC | $165.65 | 2025 | Treo Abdominal Stent-Graft System |
| Abiomed | $149.47 | 2024 | Impella |
| Hemosonics LLC | $137.56 | 2025 | Qunatra Qplus System, Quantra Qplus System |
| Masimo Corporation | $132.78 | 2024-2025 | Set and Rainbow Set, Sedline |
| Werfen USA LLC | $126.59 | 2025 | |
| Karl Storz Endoscopy-America | $36.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Markus Velten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.